Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a Western population

Gut

Volumn 67, Issue 12, 2018, Pages 2092-2096

  Doorakkers, Eva ^a   Lagergren, Jesper ^a,b   Engstrand, Lars ^c,d   Brusselaers, Nele ^c,d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c KAROLINSKA INSTITUTE   (Sweden)

^d SCIENCE FOR LIFE LABORATORY   (Sweden)

Author keywords

antibiotic therapy; gastric cancer; helicobacter pylori

Indexed keywords

ANTIINFECTIVE AGENT; PROTON PUMP INHIBITOR;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; CARDIA; COMBINATION DRUG THERAPY; COMPLICATION; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PROCEDURES; REGISTER; RISK ASSESSMENT; STOMACH TUMOR; SWEDEN; TIME FACTOR; YOUNG ADULT;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CARDIA; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PROTON PUMP INHIBITORS; REGISTRIES; RISK ASSESSMENT; STOMACH NEOPLASMS; SWEDEN; TIME FACTORS; YOUNG ADULT;

EID: 85046682982     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2017-315363     Document Type: Article

References (21)

1. Fitzmaurice C, Dicker D, Pain A, et al. The global burden of cancer 2013. JAMA Oncol 2015; 1: 505-27. doi:10.1001/jamaoncol.2015.0735.
2. The National Board of Health and Welfare. Cancer incidence in Sweden 2014. Sweden: The National Board of Health and Welfare, 2015..
3. Björkholm B, Falk P, Engstrand L, et al. Helicobacter pylori: resurrection of the cancer link. J Intern Med 2003; 253: 102-19. doi:10.1046/j.1365-2796.2003.01119.x.
4. Peleteiro B, Bastos A, Ferro A, et al. Prevalence of Helicobacter pylori infection worldwide: a systematic review of studies with national coverage. Dig Dis Sci 2014; 59: 1698-709. doi:10.1007/s10620-014-3063-0.
5. Agréus L, Hellström PM, Talley NJ, et al. Towards a healthy stomach? Helicobacter pylori prevalence has dramatically decreased over 23 years in adults in a Swedish community. United European Gastroenterol J 2016; 4: 686-96. doi:10.1177/2050640615623369.
6. McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med 2010; 362: 1597-604. doi:10.1056/NEJMcp1001110.
7. Ford AC, Forman D, Hunt RH, et al. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ 2014; 348: g3174. doi:10.1136/bmj.g3174.
8. Doorakkers E, Lagergren J, Engstrand L, et al. Eradication of Helicobacter pylori and gastric cancer: a systematic review and meta-analysis of cohort studies. J Natl Cancer Inst 2016; 108: 108. doi:10.1093/jnci/djw132.
9. Doorakkers E, Lagergren J, Gajulapuri VK, et al. Helicobacter pylori eradication in the Swedish population. Scand J Gastroenterol 2017; 52: 678-85. doi:10.1080/00365521.2017.1303844.
10. Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence consensus report. Gut 2017; 66: 6-30. doi:10.1136/gutjnl-2016-312288.
11. Jonsson F, Yin L, Lundholm C, et al. Low-dose aspirin use and cancer characteristics: a population-based cohort study. Br J Cancer 2013; 109: 1921-5. doi:10.1038/bjc.2013.411.
12. Wettermark B, Hammar N, Fored CM, et al. The new Swedish prescribed drug register: opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007; 16: 726-35. doi:10.1002/pds.1294.
13. Ekström AM, Signorello LB, Hansson LE, et al. Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst 1999; 91: 786-90. doi:10.1093/jnci/91.9.786.
14. The National Board of Health and Welfare. Causes of death 2014. Sweden: The National Board of Health and Welfare, 2015..
15. Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish National Inpatient Register. BMC Public Health 2011; 11: 450. doi:10.1186/1471-2458-11-450.
16. Breslow NE, Day NE. Statistical methods in cancer research. Volume II: the design and analysis of cohort studies. IARC Sci Publ 1987: 1-406..
17. Hernán MA, Robins JM. Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol 2016; 183: 758-64. doi:10.1093/aje/kwv254.
18. Storskrubb T, Aro P, Ronkainen J, et al. Antimicrobial susceptibility of Helicobacter pylori strains in a random adult Swedish population. Helicobacter 2006; 11: 224-30. doi:10.1111/j.1523-5378.2006.00414.x.
19. Mabe K, Takahashi M, Oizumi H, et al. Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer? World J Gastroenterol 2009; 15: 4290-7. doi:10.3748/wjg.15.4290.
20. Ma JL, Zhang L, Brown LM, et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst 2012; 104: 488-92. doi:10.1093/jnci/djs003.
21. Kosunen TU, Pukkala E, Sarna S, et al. Gastric cancers in Finnish patients after cure of Helicobacter pylori infection: a cohort study. Int J Cancer 2011; 128: 433-9. doi:10.1002/ijc.25337